UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Main results already published
Unique ID issued by UMIN UMIN000027817
Receipt No. R000031863
Scientific Title Kumamoto University Malignancy and Atheroscrelosis study
Date of disclosure of the study information 2017/06/19
Last modified on 2018/02/12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Kumamoto University Malignancy and Atheroscrelosis study
Acronym KUMA study
Scientific Title Kumamoto University Malignancy and Atheroscrelosis study
Scientific Title:Acronym KUMA study
Region
Japan

Condition
Condition Coronary artery disease
Classification by specialty
Cardiology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 The three major causes of death of the Japanese are malignant diseases, heart diseases, cerebrovascular diseases, and with the progress of aging society, opportunities to treat these disease groups tend to increase. Atherosclerotic diseases derived from lifestyle diseases such as myocardial infarction, angina pectoris, peripheral artery disease, aneurysm, cerebral infarction and the like are often conflicting and not coincidental, and in university hospitals with many complicated diseases in particular This tendency is strong, and there are times when you have difficulty in prioritizing treatment. At the present time, the coexistence rate and association of malignant tumor and atherosclerotic disease is not sufficiently clarified.
Basic objectives2 Others
Basic objectives -Others Coexistence rate of atherosclerotic disease and malignant disease will be clarified by retrospective multidisciplinary collaborative observation research.
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes In the patients with malignant disease, the history of the atherosclerosis disease and the morbidity rate are investigated.
We also investigate malignant disease complications and past history in patients with atherosclerosis disease.
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit
100 years-old >
Gender Male and Female
Key inclusion criteria Those who received percutaneous coronary intervention in our department.
Key exclusion criteria None
Target sample size 1000

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Daisuke Sueta
Organization Kumamoto University
Division name Cardiovacular Medicine
Zip code
Address 1-1-1 Honjo
TEL 096-373-5175
Email sueta-d@kumamoto-u.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Daisuke Sueta
Organization Kumamoto University
Division name Cardiovacular Medicine
Zip code
Address 1-1-1 Honjo
TEL 096-373-5175
Homepage URL
Email sueta-d@kumamoto-u.ac.jp

Sponsor
Institute Kumamoto University
Institute
Department

Funding Source
Organization Self funding
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 06 Month 19 Day

Related information
URL releasing protocol
Publication of results Published

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Main results already published
Date of protocol fixation
2017 Year 06 Month 19 Day
Date of IRB
Anticipated trial start date
2017 Year 06 Month 19 Day
Last follow-up date
2017 Year 06 Month 19 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information None

Management information
Registered date
2017 Year 06 Month 19 Day
Last modified on
2018 Year 02 Month 12 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031863

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.